MHCC shares have been crushed in the past 24 months from $1.20 to $.0003 pennies and the company recently made several bullish press releases including the hiring of their new high-powered CEO Louis Resweber who has an amazing track record of growing companies fast.
MHCC has an impressive product line, including innovative, non-invasive products such as UroVal and VasoScan that allow for more direct patient care, as well as new cash-flow streams, at a time when doctors are searching for new ways to generate revenues.
Additionally, the company recently announced partnership with a specialty medical laboratory group to provide full-service, comprehensive lab services. The lab's complete list of services include providing collection supplies, transportation services, express turn-around, and comprehensive on-line patient reporting.
A small risk of only $1,000 buys about 2,000,000 shares and if shares trade back to just 5 cents, the return is over 100 times the thousand dollars or $100,000. A price of only 2 cents would equal $20,000.
With Millennium’s business model, the diagnostic products they are getting ready to sell, the new experienced and high-powered management, and the big unmet need for them on the marketplace, this little company could easily outperform everybody’s expectations.
LJR Capital just put out a Strong Buy recommendation.